Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability
Journal of Pharmaceutical Innovation · 2027-02 · 22 (1)
DOI: 10.1007/s12247-026-11151-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 19.11.2026. Verfasst von Gulzaib Zafar und 6 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zafar, G., Afzal, H., Bukhari, N. I., Hameed, M., Kamran, S. H., Ijaz, Q. A., & Latif, S. (2027). Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability. Journal of Pharmaceutical Innovation, 22(1). https://doi.org/10.1007/s12247-026-11151-3
Vancouver
Zafar G, Afzal H, Bukhari NI, Hameed M, Kamran SH, Ijaz QA, et al. Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability. Journal of Pharmaceutical Innovation. 2027;22(1). doi:10.1007/s12247-026-11151-3
BibTeX
@article{Zafar2027,
author = {Zafar, Gulzaib and Afzal, Hafsa and Bukhari, Nadeem Irfan and Hameed, Misbah and Kamran, Sairah Hafeez and Ijaz, Qazi Amir and Latif, Sumera},
title = {Empagliflozin Nano-cocrystals with Citric and Ascorbic Acids: A Cocrystal Nanonization Strategy for Modulation of Solubility, Permeability, Flowability, Pharmacodynamic Effect and Stability},
journal = {Journal of Pharmaceutical Innovation},
year = {2027},
volume = {22},
number = {1},
doi = {10.1007/s12247-026-11151-3}
}
EUVIMED